WNT Scientific LLC
- Biotech or pharma, therapeutic R&D
- Diagnostics
We are a preclinical-stage biotechnology company dedicated to developing regenerative therapeutics for musculoskeletal disorders. Our mission is to address unmet clinical needs by creating innovative, disease-modifying treatments that restore tissue function and improve patient outcomes. Our lead program is a disease-modifying osteoarthritis drug designed to repair osteoarthritic joints, supported by robust efficacy data in both knee and temporomandibular joint (TMJ) osteoarthritis animal models. Our diversified pipeline also includes an angiogenic factor to promote fracture healing, osteogenic stem cells for the regeneration of critical-sized bone defects, and small-molecule therapeutics for tendon injury. Our technologies are supported by strong preclinical data and multiple NIH-funded programs, positioning us to advance novel treatments into clinical development.
Address
New YorkNew York
United States
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}